Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and treating psychiatric disorders in a patient

Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and treating psychiatric disorders in a patient

US Patent 11174514 · Granted Nov 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric 2025
Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric 2025
Methods for treating cognitive deficits in a subject having schizophrenia, bipol2023
Array-based methods for analysing mixed samples using differently labelled allel2023
Array-based methods for analysing mixed samples using different allele-specific 2022
Beta-carbolines as positive allosteric modulators of the human serotonin recepto2022
Enantioselective syntheses of heteroyohimbine natural product intermediates2020
Method of treating fulminant hepatic failure using DLL4 cytokine2019
Enantioselective syntheses of heteroyohimbine natural product intermediates2019
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to 2018
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to 2018
Polyanthrylene materials and methods for their preparation and use2014